Female patients less likely to receive invasive care - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Female patients less likely to receive invasive care

Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.

  • By

  • Andrea Surnit

  • September 23, 2026

  • 5 min

Share

Clinical Scorecard: Female patients less likely to receive invasive care

At a Glance

CategoryDetail
ConditionSex-based differences in patient management
Key MechanismsVariations in treatment approaches based on sex, including invasive and intensive care disparities.
Target PopulationPatients with comparable clinical characteristics across various medical specialties.
Care SettingMultiple medical specialties including cardiovascular medicine, neurology, surgery, and emergency medicine.

Key Highlights

  • Female patients are less likely to receive invasive treatments compared to male patients.
  • 87% of retrospective studies reported significant treatment differences based on sex.
  • Cardiovascular studies showed females receiving more conservative management.
  • Male patients were more likely to receive referrals for procedures like deep brain stimulation.
  • Differences in treatment did not consistently indicate inequity.

Guideline-Based Recommendations

Diagnosis

  • Consider sex as a factor in clinical decision-making.

Management

  • Evaluate treatment approaches for potential sex-based disparities.

Monitoring & Follow-up

  • Monitor outcomes by sex to assess treatment effectiveness.

Risks

  • Recognize potential systemic inequities affecting treatment access.

Patient & Prescribing Data

Patients evaluated across various specialties, including cardiovascular and emergency medicine.

Female patients often receive less invasive care and may have different treatment outcomes.

Clinical Best Practices

  • Incorporate sex-specific clinical guidelines in treatment assessments.
  • Conduct prospective studies with robust adjustment for confounders.
  • Address intersectional characteristics in patient management.

Related Resources & Content

Original Source(s)

Female patients less likely to receive invasive care

  • by Andrea Surnit

  • September 23, 2026

Related Content

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

Enterovirus diversity may limit treatment advances

Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.

HHS Proposes Mandatory GRAS Notices

Manufacturers would be required to notify the FDA of GRAS determinations under a proposed rule, while HHS and USDA also submitted the first proposed federal definition of ultra-processed foods for final review.